[1] Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: mechanistic concepts and therapeutic perspectives. Cells,2020,9(4):875. [2] Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol,2011,6:425-56. [3] Lai M, Afdhal NH. Liver fibrosis determination. Gastroenterol Clin North Am,2019,48(2):281-289. [4] Ferraioli G, Barr RG. Ultrasound liver elastography beyond liver fibrosis assessment. World J Gastroenterol,2020,26(24):3413-3420. [5] Fan Y, Yu Y, Hu M, et al. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma. Br J Radiol,2021,94(1119):20200950. [6] Pan S, Wang L, Xin J. Combining 18F-FDG PET and Gd-EOB-DTPA-enhanced MRI for staging liver fibrosis. Life Sci,2021,269:119086. [7] 肖珊珊, 杨巧红, 李建婷. 低水平HBsAg慢性乙型肝炎患者炎症分级及纤维化分期观察. 肝脏,2022,27(2):225-227. [8] 李晓明, 蔡萍, 程琳, 等. 钆塞酸二钠增强磁共振成像检查术前诊断粗梁-团块型肝细胞肝癌的临床价值. 中华消化外科杂志,2021,20(11):1218-1226. [9] 胡景卉,王笑笑,黄京城,等.Gd-EOB-DTPA增强MRI对肝肿瘤术前肝储备功能评估的临床价值.中国中西医结合影像学杂志,2022,20(3):233-238. [10] Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis,2017, 37(1):1-10. [11] 孟海生, 胡冬梅, 李莎莎, 等. 超声量化指标与肝静脉波形分型在评价乙肝患者肝纤维化程度中的临床意义. 中国超声医学杂志,2021,37(1):59-62. [12] Verloh N, Utpatel K, Haimerl M, et al. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: a confirmatory study. Sci Rep,2018,8(1):6207. |